355
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES Clinical Translational Therapeutics

Capecitabine, Oxaliplatin and Radiotherapy: A Phase IB Neoadjuvant Study for Esophageal Cancer with Gene Expression Analysis

, , , , , , , , , , , & show all
Pages 193-200 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Gianluca Tomasello, Michele Ghidini, Sandro Barni, Rodolfo Passalacqua & Fausto Petrelli. (2017) Overview of different available chemotherapy regimens combined with radiotherapy for the neoadjuvant and definitive treatment of esophageal cancer. Expert Review of Clinical Pharmacology 10:6, pages 649-660.
Read now
Elizabeta C Popa & Manish A Shah. (2013) Capecitabine in the treatment of esophageal and gastric cancers. Expert Opinion on Investigational Drugs 22:12, pages 1645-1657.
Read now

Articles from other publishers (12)

Surya K. De. 2022. Fundamentals of Cancer Detection, Treatment, and Prevention. Fundamentals of Cancer Detection, Treatment, and Prevention 371 393 .
Laura B. Vater, Bénédicte Lefebvre, Anita Turk & Suparna C. Clasen. (2022) Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge. Current Oncology Reports 24:7, pages 943-950.
Crossref
Jen-Hao Yeh, Yung-Sung Yeh, Hsiang-Lin Tsai, Ching-Wen Huang, Tsung-Kun Chang, Wei-Chih Su & Jaw-Yuan Wang. (2022) Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?. Cancers 14:12, pages 3026.
Crossref
Usha Malhotra, Sarbajit Mukherjee, Christos Fountzilas, Patrick Boland, Austin Miller, Santosh Patnaik, Kristopher Attwood, Sai Yendamuri, Araba Adjei, Eric Kannisto, Mateusz Opyrchal, Peter Bushunow, Peter Loud, Renuka Iyer & Nikhil Khushalani. (2020) Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates. Molecular Cancer Therapeutics 19:1, pages 304-311.
Crossref
Daniela Barone, Letizia Cito, Giuseppina Tommonaro, Agnese A. Abate, Danila Penon, Rocco De Prisco, Antonella Penon, Iris M. Forte, Elisabetta Benedetti, Annamaria Cimini, Paola Indovina, Barbara Nicolaus, Francesca Pentimalli & Antonio Giordano. (2017) Antitumoral potential, antioxidant activity and carotenoid content of two Southern Italy tomato cultivars extracts: San Marzano and Corbarino. Journal of Cellular Physiology 233:2, pages 1266-1277.
Crossref
Somnath Mukherjee, Christopher Nicholas Hurt, Sarah Gwynne, David Sebag-Montefiore, Ganesh Radhakrishna, Simon Gollins, Maria Hawkins, Heike I. Grabsch, Gareth Jones, Stephen Falk, Ricky Sharma, Andrew Bateman, Rajarshi Roy, Ruby Ray, Jo Canham, Gareth Griffiths, Tim Maughan & Tom Crosby. (2017) NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma. European Journal of Cancer 74, pages 38-46.
Crossref
Somnath Mukherjee, Christopher N Hurt, Sarah Gwynne, Andrew Bateman, Simon Gollins, Ganesh Radhakrishna, Maria Hawkins, Jo Canham, Wyn Lewis, Heike I Grabsch, Ricky A Sharma, Wendy Wade, Rhydian Maggs, Bethan Tranter, Ashley Roberts, David Sebag-Montefiore, Timothy Maughan, Gareth Griffiths & Tom Crosby. (2015) NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma. BMC Cancer 15:1.
Crossref
S. Gwynne, S. Falk, S. Gollins, L. Wills, A. Bateman, S. Cummins, H. Grabsch, M.A. Hawkins, R. Maggs, S. Mukherjee, G. Radhakrishna, R. Roy, R.A. Sharma, E. Spezi & T. Crosby. (2013) Oesophageal Chemoradiotherapy in the UK—Current Practice and Future Directions. Clinical Oncology 25:6, pages 368-377.
Crossref
Esme J. Hill, Nils H. Nicolay, Mark R. Middleton & Ricky A. Sharma. (2012) Oxaliplatin as a radiosensitiser for upper and lower gastrointestinal tract malignancies: What have we learned from a decade of translational research?. Critical Reviews in Oncology/Hematology 83:3, pages 353-387.
Crossref
E. Gabriela Chiorean, Sonal Sanghani, Marissa A. Schiel, Menggang Yu, Matthew Burns, Yan Tong, David T. Hinkle, Nicki Coleman, Bruce Robb, Julia LeBlanc, Romnee Clark, Jose Bufill, Colleen Curie, Patrick J. Loehrer & Higinia Cardenes. (2012) Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53. Cancer Chemotherapy and Pharmacology 70:1, pages 25-32.
Crossref
S. Gwynne, C. Hurt, M. Evans, C. Holden, L. Vout & T. Crosby. (2011) Definitive Chemoradiation for Oesophageal Cancer — a Standard of Care in Patients with Non-metastatic Oesophageal Cancer. Clinical Oncology 23:3, pages 182-188.
Crossref
Kilian S. May, Gary Y. Yang & Nikhil I. Khushalani. (2011) The Role of Radiation in the Perioperative Treatment of Esophagogastric Cancer. Current Treatment Options in Oncology 12:1, pages 61-71.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.